Grading of Atypia in Nevi: Correlation with Melanoma Risk

Nevi with architectural disorder and cytologic atypia of melanocytes (NAD), aka “dysplastic nevi,” have varying degrees of histologic abnormalities, which can be considered on a spectrum of grades of atypia. Somewhat controversial and subjective criteria have been developed for grading of NAD into t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern pathology 2003-08, Vol.16 (8), p.764-771
Hauptverfasser: Arumi-Uria, Montserrat, McNutt, N Scott, Finnerty, Bridget
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 771
container_issue 8
container_start_page 764
container_title Modern pathology
container_volume 16
creator Arumi-Uria, Montserrat
McNutt, N Scott
Finnerty, Bridget
description Nevi with architectural disorder and cytologic atypia of melanocytes (NAD), aka “dysplastic nevi,” have varying degrees of histologic abnormalities, which can be considered on a spectrum of grades of atypia. Somewhat controversial and subjective criteria have been developed for grading of NAD into three categories “mild,” “moderate,” and “severe.” Grading involves architectural and cytological features, which often correlate with each other. Architectural criteria were intraepidermal junctional extension beyond any dermal component, complex distortion of rete ridges, and dermal fibrosis. Cytological criteria were based on nuclear size, dispersion of chromatin, prominence of nucleoli, hyperchromasia and variation in nuclear staining. Few tests have been made of the relationship between specific grades of atypia and patient risk for melanoma. Retrospective review of pathology reports was performed on 20,275 nevi examined between 1989 and 1996. From the total, 6,275 were diagnosed as NAD, which were in 4,481 patients. These patients were divided into those whose worst NAD was mild (2,504), moderate (1,657), or severe (320). Review of accession data revealed that a personal history of melanoma was present in 5.7% of patients with mild, 8.1% with moderate, and 19.7% with severe atypia. The male/female ratios were similar in each group. In the three groups, the mean ages of men were similar and of women were similar, but the mean age of men tended to be 6–11 yrs. older than women in each group. Family histories of melanoma were not considered. The odds ratio as a measure of association between NAD and personal history of melanoma, shows an odds ratio of 4.08 (2.91–5.7) for NAD-severe versus NAD mild, odds ratio 2.81 (2–3.95) for NAD-severe versus NAD-moderate and odds ratio 1.45 (1.13–1.87) for NAD moderate versus NAD-mild. These data show that the probability of having personal history of melanoma, for any given NAD patient, correlates with the NAD grade. Likewise, the risk of melanoma is greater for persons who tend to make nevi with high grade histological atypia.
doi_str_mv 10.1097/01.MP.0000082394.91761.E5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73569717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0893395222047457</els_id><sourcerecordid>984492531</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-45ef6c5902176744066610fe5ee381257daa0cbcff52e128ea171eba5a6e26013</originalsourceid><addsrcrecordid>eNqNkEFv1DAQhS1ERbeFnwAKHLglzNhxYvdWrZZSqQsVgrPldSbFZTfZ2klR_329ZNWVeqovljXfe_P8GPuIUCDo-gtgsbwuYHcUF7osNNYVFgv5is1QCsiBK_mazUBpkQst-TE7ifEWAEup-Bt2jFxz4BxmTF8E2_juJuvb7Hx42Hqb-S77Tvf-LJv3IdDaDr7vsn9--JMt06vrNzb76ePft-yotetI7_b3Kfv9dfFr_i2_-nFxOT-_yp3k5ZCXktrKSQ08ZazLEqqqQmhJEgmFXNaNteBWrm0lJ-SKLNZIKyttRbwCFKfs8-S7Df3dSHEwGx8drVMU6sdoaiErXWOdwE_PwNt-DF3KZjhHLriGMkF6glzoYwzUmm3wGxseDILZlWsAzfLaHMo1_8s1C5m0H_YLxtWGmoNy32YCziYgplF3Q-GQ4CXu7ydxZ4cx0JO7UAqU2H1vPs0plX3vk3l0njpHjQ_kBtP0_gVbHgFreqNC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221232904</pqid></control><display><type>article</type><title>Grading of Atypia in Nevi: Correlation with Melanoma Risk</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Arumi-Uria, Montserrat ; McNutt, N Scott ; Finnerty, Bridget</creator><creatorcontrib>Arumi-Uria, Montserrat ; McNutt, N Scott ; Finnerty, Bridget</creatorcontrib><description>Nevi with architectural disorder and cytologic atypia of melanocytes (NAD), aka “dysplastic nevi,” have varying degrees of histologic abnormalities, which can be considered on a spectrum of grades of atypia. Somewhat controversial and subjective criteria have been developed for grading of NAD into three categories “mild,” “moderate,” and “severe.” Grading involves architectural and cytological features, which often correlate with each other. Architectural criteria were intraepidermal junctional extension beyond any dermal component, complex distortion of rete ridges, and dermal fibrosis. Cytological criteria were based on nuclear size, dispersion of chromatin, prominence of nucleoli, hyperchromasia and variation in nuclear staining. Few tests have been made of the relationship between specific grades of atypia and patient risk for melanoma. Retrospective review of pathology reports was performed on 20,275 nevi examined between 1989 and 1996. From the total, 6,275 were diagnosed as NAD, which were in 4,481 patients. These patients were divided into those whose worst NAD was mild (2,504), moderate (1,657), or severe (320). Review of accession data revealed that a personal history of melanoma was present in 5.7% of patients with mild, 8.1% with moderate, and 19.7% with severe atypia. The male/female ratios were similar in each group. In the three groups, the mean ages of men were similar and of women were similar, but the mean age of men tended to be 6–11 yrs. older than women in each group. Family histories of melanoma were not considered. The odds ratio as a measure of association between NAD and personal history of melanoma, shows an odds ratio of 4.08 (2.91–5.7) for NAD-severe versus NAD mild, odds ratio 2.81 (2–3.95) for NAD-severe versus NAD-moderate and odds ratio 1.45 (1.13–1.87) for NAD moderate versus NAD-mild. These data show that the probability of having personal history of melanoma, for any given NAD patient, correlates with the NAD grade. Likewise, the risk of melanoma is greater for persons who tend to make nevi with high grade histological atypia.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1097/01.MP.0000082394.91761.E5</identifier><identifier>PMID: 12920220</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Atypia ; Dysplastic nevus ; Dysplastic Nevus Syndrome - pathology ; Female ; Humans ; Laboratory Medicine ; Male ; Malignant melanoma ; Medicine ; Medicine &amp; Public Health ; Melanoma - pathology ; Middle Aged ; Odds Ratio ; original-article ; Pathology ; Precancerous Conditions - pathology ; Retrospective Studies ; Risk Factors ; Skin Neoplasms - pathology</subject><ispartof>Modern pathology, 2003-08, Vol.16 (8), p.764-771</ispartof><rights>2003 United States &amp; Canadian Academy of Pathology</rights><rights>The United States and Canadian Academy of Pathology, Inc. 2003</rights><rights>Copyright Nature Publishing Group Aug 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-45ef6c5902176744066610fe5ee381257daa0cbcff52e128ea171eba5a6e26013</citedby><cites>FETCH-LOGICAL-c524t-45ef6c5902176744066610fe5ee381257daa0cbcff52e128ea171eba5a6e26013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/221232904?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,27911,27912,64370,64372,64374,72226</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12920220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arumi-Uria, Montserrat</creatorcontrib><creatorcontrib>McNutt, N Scott</creatorcontrib><creatorcontrib>Finnerty, Bridget</creatorcontrib><title>Grading of Atypia in Nevi: Correlation with Melanoma Risk</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>Nevi with architectural disorder and cytologic atypia of melanocytes (NAD), aka “dysplastic nevi,” have varying degrees of histologic abnormalities, which can be considered on a spectrum of grades of atypia. Somewhat controversial and subjective criteria have been developed for grading of NAD into three categories “mild,” “moderate,” and “severe.” Grading involves architectural and cytological features, which often correlate with each other. Architectural criteria were intraepidermal junctional extension beyond any dermal component, complex distortion of rete ridges, and dermal fibrosis. Cytological criteria were based on nuclear size, dispersion of chromatin, prominence of nucleoli, hyperchromasia and variation in nuclear staining. Few tests have been made of the relationship between specific grades of atypia and patient risk for melanoma. Retrospective review of pathology reports was performed on 20,275 nevi examined between 1989 and 1996. From the total, 6,275 were diagnosed as NAD, which were in 4,481 patients. These patients were divided into those whose worst NAD was mild (2,504), moderate (1,657), or severe (320). Review of accession data revealed that a personal history of melanoma was present in 5.7% of patients with mild, 8.1% with moderate, and 19.7% with severe atypia. The male/female ratios were similar in each group. In the three groups, the mean ages of men were similar and of women were similar, but the mean age of men tended to be 6–11 yrs. older than women in each group. Family histories of melanoma were not considered. The odds ratio as a measure of association between NAD and personal history of melanoma, shows an odds ratio of 4.08 (2.91–5.7) for NAD-severe versus NAD mild, odds ratio 2.81 (2–3.95) for NAD-severe versus NAD-moderate and odds ratio 1.45 (1.13–1.87) for NAD moderate versus NAD-mild. These data show that the probability of having personal history of melanoma, for any given NAD patient, correlates with the NAD grade. Likewise, the risk of melanoma is greater for persons who tend to make nevi with high grade histological atypia.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Atypia</subject><subject>Dysplastic nevus</subject><subject>Dysplastic Nevus Syndrome - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Malignant melanoma</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melanoma - pathology</subject><subject>Middle Aged</subject><subject>Odds Ratio</subject><subject>original-article</subject><subject>Pathology</subject><subject>Precancerous Conditions - pathology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Skin Neoplasms - pathology</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkEFv1DAQhS1ERbeFnwAKHLglzNhxYvdWrZZSqQsVgrPldSbFZTfZ2klR_329ZNWVeqovljXfe_P8GPuIUCDo-gtgsbwuYHcUF7osNNYVFgv5is1QCsiBK_mazUBpkQst-TE7ifEWAEup-Bt2jFxz4BxmTF8E2_juJuvb7Hx42Hqb-S77Tvf-LJv3IdDaDr7vsn9--JMt06vrNzb76ePft-yotetI7_b3Kfv9dfFr_i2_-nFxOT-_yp3k5ZCXktrKSQ08ZazLEqqqQmhJEgmFXNaNteBWrm0lJ-SKLNZIKyttRbwCFKfs8-S7Df3dSHEwGx8drVMU6sdoaiErXWOdwE_PwNt-DF3KZjhHLriGMkF6glzoYwzUmm3wGxseDILZlWsAzfLaHMo1_8s1C5m0H_YLxtWGmoNy32YCziYgplF3Q-GQ4CXu7ydxZ4cx0JO7UAqU2H1vPs0plX3vk3l0njpHjQ_kBtP0_gVbHgFreqNC</recordid><startdate>20030801</startdate><enddate>20030801</enddate><creator>Arumi-Uria, Montserrat</creator><creator>McNutt, N Scott</creator><creator>Finnerty, Bridget</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20030801</creationdate><title>Grading of Atypia in Nevi: Correlation with Melanoma Risk</title><author>Arumi-Uria, Montserrat ; McNutt, N Scott ; Finnerty, Bridget</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-45ef6c5902176744066610fe5ee381257daa0cbcff52e128ea171eba5a6e26013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Atypia</topic><topic>Dysplastic nevus</topic><topic>Dysplastic Nevus Syndrome - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Malignant melanoma</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melanoma - pathology</topic><topic>Middle Aged</topic><topic>Odds Ratio</topic><topic>original-article</topic><topic>Pathology</topic><topic>Precancerous Conditions - pathology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Skin Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arumi-Uria, Montserrat</creatorcontrib><creatorcontrib>McNutt, N Scott</creatorcontrib><creatorcontrib>Finnerty, Bridget</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arumi-Uria, Montserrat</au><au>McNutt, N Scott</au><au>Finnerty, Bridget</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Grading of Atypia in Nevi: Correlation with Melanoma Risk</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2003-08-01</date><risdate>2003</risdate><volume>16</volume><issue>8</issue><spage>764</spage><epage>771</epage><pages>764-771</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>Nevi with architectural disorder and cytologic atypia of melanocytes (NAD), aka “dysplastic nevi,” have varying degrees of histologic abnormalities, which can be considered on a spectrum of grades of atypia. Somewhat controversial and subjective criteria have been developed for grading of NAD into three categories “mild,” “moderate,” and “severe.” Grading involves architectural and cytological features, which often correlate with each other. Architectural criteria were intraepidermal junctional extension beyond any dermal component, complex distortion of rete ridges, and dermal fibrosis. Cytological criteria were based on nuclear size, dispersion of chromatin, prominence of nucleoli, hyperchromasia and variation in nuclear staining. Few tests have been made of the relationship between specific grades of atypia and patient risk for melanoma. Retrospective review of pathology reports was performed on 20,275 nevi examined between 1989 and 1996. From the total, 6,275 were diagnosed as NAD, which were in 4,481 patients. These patients were divided into those whose worst NAD was mild (2,504), moderate (1,657), or severe (320). Review of accession data revealed that a personal history of melanoma was present in 5.7% of patients with mild, 8.1% with moderate, and 19.7% with severe atypia. The male/female ratios were similar in each group. In the three groups, the mean ages of men were similar and of women were similar, but the mean age of men tended to be 6–11 yrs. older than women in each group. Family histories of melanoma were not considered. The odds ratio as a measure of association between NAD and personal history of melanoma, shows an odds ratio of 4.08 (2.91–5.7) for NAD-severe versus NAD mild, odds ratio 2.81 (2–3.95) for NAD-severe versus NAD-moderate and odds ratio 1.45 (1.13–1.87) for NAD moderate versus NAD-mild. These data show that the probability of having personal history of melanoma, for any given NAD patient, correlates with the NAD grade. Likewise, the risk of melanoma is greater for persons who tend to make nevi with high grade histological atypia.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>12920220</pmid><doi>10.1097/01.MP.0000082394.91761.E5</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-3952
ispartof Modern pathology, 2003-08, Vol.16 (8), p.764-771
issn 0893-3952
1530-0285
language eng
recordid cdi_proquest_miscellaneous_73569717
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection
subjects Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Atypia
Dysplastic nevus
Dysplastic Nevus Syndrome - pathology
Female
Humans
Laboratory Medicine
Male
Malignant melanoma
Medicine
Medicine & Public Health
Melanoma - pathology
Middle Aged
Odds Ratio
original-article
Pathology
Precancerous Conditions - pathology
Retrospective Studies
Risk Factors
Skin Neoplasms - pathology
title Grading of Atypia in Nevi: Correlation with Melanoma Risk
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A20%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Grading%20of%20Atypia%20in%20Nevi:%20Correlation%20with%20Melanoma%20Risk&rft.jtitle=Modern%20pathology&rft.au=Arumi-Uria,%20Montserrat&rft.date=2003-08-01&rft.volume=16&rft.issue=8&rft.spage=764&rft.epage=771&rft.pages=764-771&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1097/01.MP.0000082394.91761.E5&rft_dat=%3Cproquest_cross%3E984492531%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221232904&rft_id=info:pmid/12920220&rft_els_id=S0893395222047457&rfr_iscdi=true